Radiopaedia Helpers

Headings Spacing

error

"Epidemiology "

Line 4:1 · Never put spaces at either end of headings.

Units

error

"Low-grade fibromyxoid sarcomas regularly show either FUS-CREB3L2 or FUS-CREB3L1 gene fusions ¹."

Line 41:69 · Put a space between the number and the unit in '3L'.

"Low-grade fibromyxoid sarcomas regularly show either FUS-CREB3L2 or FUS-CREB3L1 gene fusions ¹."

Line 41:93 · Put a space between the number and the unit in '3L'.

Strong List Colon Position

error

"T2FS/PDFS: iso- to hyperintense"

Line 71:1 · When enboldening an intro, the colon should not be bold. 'T2FS/PDFS: iso'

"DWI: diffusion restriction"

Line 73:1 · When enboldening an intro, the colon should not be bold. 'DWI: diffusion'

"T1 C+ (Gd): inhomogeneous or alternating or gyriform patterns of enhancement"

Line 75:1 · When enboldening an intro, the colon should not be bold. 'T1 C+ (Gd): inhomogeneous'

Strong

warning

"The term hyalinizing spindle cell tumour with giant rosettes is now discouraged."

Line 3:13 · Generally, don't use bold in text: 'hyalinizing spindle cell tumour with giant rosettes'

"T1"

Line 57:1 · Generally, don't use bold in text: 'T1'

"T2"

Line 64:1 · Generally, don't use bold in text: 'T2'

"T2FS/PDFS: iso- to hyperintense"

Line 71:1 · Generally, don't use bold in text: 'T2FS/PDFS:'

"DWI: diffusion restriction"

Line 73:1 · Generally, don't use bold in text: 'DWI:'

"T1 C+ (Gd): inhomogeneous or alternating or gyriform patterns of enhancement"

Line 75:1 · Generally, don't use bold in text: 'T1 C+ (Gd): '

"T1 C+ (Gd): inhomogeneous or alternating or gyriform patterns of enhancement"

Line 75:30 · Generally, don't use bold in text: 'inhomogeneous or alternating or gyriform patterns of enhancement'

Acronyms

warning

"Immunohistochemistry stains express MUC4 in a very high number of cases, which is highly sensitive and specific for low low-grade fibromyxoid sarcomas and sclerosing epithelioid fibrosarcoma. Other expressions include CD99, BCL2, EMA and vimentin in many cases as well as smooth muscle actin in a low number ^1,2,5."

Line 39:244 · 'EMA' has no definition. Spell it out if it's unfamiliar to the audience.

Emphasis

warning

"Low-grade fibromyxoid sarcomas regularly show either FUS-CREB3L2 or FUS-CREB3L1 gene fusions ¹."

Line 41:57 · Italics should be used only in exceptional circumstances: 'FUS-CREB3L2'

List Caps

warning

"Morel-Lavallée lesion"

Line 97:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Epidemiology "

Line 4:1 · "Epidemiology " is not a recognised heading for this article type.

Oxford Comma

suggestion

"The diagnosis of low-grade fibromyxoid sarcoma is established by histological, immunohistochemical and molecular criteria ¹."

Line 7:69 · Use the Oxford comma in 'histological, immunohistochemical and molecular'.

"Immunohistochemistry stains express MUC4 in a very high number of cases, which is highly sensitive and specific for low low-grade fibromyxoid sarcomas and sclerosing epithelioid fibrosarcoma. Other expressions include CD99, BCL2, EMA and vimentin in many cases as well as smooth muscle actin in a low number ^1,2,5."

Line 39:235 · Use the Oxford comma in 'BCL2, EMA and vimentin'.

"form, location and size"

Line 80:5 · Use the Oxford comma in 'form, location and size'.

"Recurrences and metastasis are low within the first five years after excision but much higher in the long term with overall recurrence rates higher than 60% and a fatality rate of over 40%. Metastases have been observed even more than 40 years after primary resection. The most common sites for metastasis are the lung, pleura, bone and liver ^1-3."

Line 87:334 · Use the Oxford comma in 'pleura, bone and liver'.

Biographical Lifespan

suggestion

"History and etymology"

Line 88:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> Low-grade fibromyxoid sarcoma was first described by an American pathologist Harry L Evans '

Lint: low-grade-fibromyxoid-sarcoma